arrow
L

Lucie Barateau

Chu
H指数:34
被引数:3,446

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

0723 Effects of Treatment with Oveporexton, an Orexin Receptor 2 Agonist, on Sleep in People with Narcolepsy Type 1: Phase 3 Results

0723 Oveporexton(一种食欲素受体2激动剂)治疗对发作性睡病1型患者睡眠的影响:III期试验结果

Sleep
IF4.9
2026-05-080
PRE
0733 Effect of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist, on Narcolepsy Type 1 Symptom Severity: A Pooled Analysis of Two Phase 3 Studies

0733 Oveporexton(TAK-861),一种口服食欲素受体2激动剂,对发作性睡病1型症状严重程度的影响:两项III期研究的合并分析

Sleep
IF4.9
2026-05-080
PRE
The Hidden Burden of Narcolepsy Type 1: Discordance in Psychobehavioral Symptoms Between Patient Self-Reports and Reports from Close Family Members and Friends

发作性睡病1型的隐性负担:患者自我报告与来自亲密家庭成员和朋友报告在心理行为症状上的不一致

2026-04-190
PRE
Underestimation of nocturnal sleep duration in central disorders of hypersomnolence: an underrecognized feature?

对发作性睡病中枢性障碍中夜间睡眠时长的低估:这是一个未被充分认识的特征?

2025-12-010
PRE
A new decision-making approach for residual excessive daytime sleepiness in individuals treated for obstructive sleep apnea-hypopnea syndrome: the blob-algorithm proposition

针对接受治疗的阻塞性睡眠呼吸暂停-低通气综合征患者中残留过度日间嗜睡的一种新的决策方法:blob-algorithm提案

SLEEP
IF4.9
2025-11-010
PRE
Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study
2025-05-010
OAAI